menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’

2 2
23.09.2024
The success of Novo’s weight-loss treatments has transformed the drugmaker into Europe’s most valuable company and made it a key driver of domestic...

© Fortune